— Medical and Science Team of Leading Experts Aim for Global Results
/EIN News/ — VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTC: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a premier California based multi-faceted life sciences company focused on the commercialization of Cannabis products and advanced formulations, is pleased to announce the launch of concerted efforts to develop “precision cannabis” products targeting the delivery of the “right formulation to the right individual at the right time.” Juva plans to develop intellectual property and secure patent protection on each of its custom formulations and will focus its research registries in areas of inflammation, oncology, neurology, pain management, sleep, menopausal symptoms, and opiate reduction.
Juva’s CEO and Founder, Doug Chloupek, has been the driving force in assembling a top team of leading professionals who come to Juva from major enterprises such as Bristol-Meyers Squibb, to prestigious high-profile organizations and academic institutions. These interdisciplinary experts are actively moving forward with research and data collection to support the creation of specialized formulations aimed at addressing a broad range of sometimes devastating disorders. As an outcome of…
Original Author Link click here to read complete story..
